METEOR trial results: Cabozantinib improves advanced kidney cancer survival
26 Sep 2015
METEOR trial results: Cabozantinib improves advanced kidney cancer survival
The LRF CLL4 trial: long-term outcomes
CLL from a patient and physician perspective
Risk of bleeding-related adverse events in ibrutinib treated CLL patients
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy
Will chemotherapy remain the cornerstone of CLL management?
Aspirin for cancer treatment and prevention
Mechanisms behind bleeding with aspirin
Effects of aspirin on colorectal cancer
ecancermedicalscience editor's choice for August 2015
Robotic surgery and oropharyngeal cancer
Developments in research and prevention in head, neck and oral cancer